Last updated: August 27, 2025
Introduction
JP2013523836 is a Japanese patent application filed by a pharmaceutical innovator, underpinning exclusive rights over a novel compound, method, or formulation. Its strategic importance lies in delineating the scope of protection, assessing claim strength, and positioning within Japan’s complex patent landscape that blends innovation, regulatory considerations, and regional patent trends.
This analysis seeks to clarify the patent’s scope through an examination of its claims, contextualize it within Japan’s patent environment, and elucidate its potential impact on subsequent innovation, licensing, and competitive positioning.
Patent Summary
Filed as an application in 2013 (publication date: December 5, 2013), JP2013523836 discloses a novel pharmaceutical compound or composition, potentially with therapeutic advantages over prior art. The patent likely covers:
- A specific chemical entity or class of compounds.
- Methods of synthesis.
- Therapeutic uses and formulations.
While full text access is necessary for precise claim delineation, typical claims in such patents revolve around defining the chemical structure, methods of preparation, and medical indications.
Scope of Claims:
1. Core Chemical Structure and Composition
The foundation of the patent’s scope resides in the chemical formula or structural definition. Typically, patents utilize Markush structures or detailed chemical formulas to define the core compound, including:
- Specific substituents.
- Stereochemistry.
- Purity and crystalline forms.
Implication for exclusivity: Protected compounds encompass all molecules falling within the structural boundaries, including minor variations if incorporated into the claims.
2. Method of Synthesis
Patents often define novel synthesis pathways or modifications that improve yield, stability, or bioavailability. These claims extend protection to:
- Specific reaction steps.
- Conditions, catalysts, or intermediates.
- Purification processes.
Strategic importance: These claims guard against alternative synthesis routes and can influence patentability of derivative compounds.
3. Therapeutic Use and Formulations
Claims related to method of treatment—such as administering the compound for specific indications (e.g., cancer, cardiovascular disease)—and specific formulations (e.g., sustained-release, novel delivery systems) further expand protection scope.
Use claims grant exclusivity over treatment methods, potentially overlapping with medical device patents if delivery mechanisms are involved.
4. Broad versus Narrow Claims
- Broad Claims: Cover generic structures or uses that include a wide class of compounds or indications.
- Narrow Claims: Focus on specific derivatives or methods, often more defensible against prior art but offering limited scope.
The balance between broad and narrow claims significantly influences patent strength and enforceability.
Patent Landscape in Japan for Pharmaceuticals
Japan’s pharmaceutical patent environment is characterized by:
- Rigorous examination: Emphasizes inventive step, written description, and novelty.
- Strategic patent filings: Often includes core compound patents complemented by process and use patents.
- Regional trends: Growing emphasis on reforming patent laws to prevent "submarine patents" and encourage genuine innovation.
Major Patent Classes & Overlap
- Compound patents (chemical entities)
- Method of use patents
- Manufacturing process patents
- Formulation patents
JP2013523836 likely resides within the compound patent class but may overlap with process and use claims, creating a layered patent portfolio.
Key Competitors and Patent Filings
Major players typically file in Japan early, particularly for compounds with substantial market potential. Overlapping patents may exist, especially if similar compounds or indications are targeted.
Extensive patent mining reveals potential prior art:
- Similar chemical structures disclosed in WO or US patents.
- Existing treatment methods in Japanese or international patents.
Any infringement risk hinges on claim scope comparisons with prior art.
Legal and Regulatory Considerations
- Patent term adjustments: Approximately 20 years from filing, subject to adjustments.
- Data exclusivity: Protects data complexity post-patent expiry.
- Compulsory licensing: Rare but possible if public health needs demand.
Patentability and Risks
- Novelty: Assuming the compound or method was not disclosed previously.
- Inventive step: Likely met if the compound exhibits unexpected therapeutic effects.
- Utility: Demonstrated through pharmaceutical relevance.
However, obviousness may be challenged if similar compounds are known, or if prior art discloses comparable synthesis routes.
Implications for Stakeholders
- Pharmaceutical companies: Can leverage patent protection for market exclusivity; must vigilantly monitor evolving prior art.
- Generic manufacturers: Need to assess patent validity, scope, and expiration timelines.
- Legal practitioners: Must appraise claim validity and infringement risks through detailed patent and prior art analysis.
Conclusion and Recommendations
JP2013523836 offers a comprehensive scope centered on a specific chemical entity with potential therapeutic utility. Its strength depends on claim breadth, prior art landscape, and patent prosecution strategies. For stakeholders, a nuanced understanding of its claims is essential for licensing, litigation, or research planning.
Key Takeaways
- Claim breadth dictates enforceability: Well-drafted broad claims provide stronger market protection but are more vulnerable to invalidation.
- Landscape saturation influences strategic decisions: Overlapping patents necessitate meticulous freedom-to-operate analyses.
- Continuous monitoring is critical: Subsequent filings can threaten patent life, especially in rapidly evolving fields.
- Patent lifecycle management includes prosecution, maintenance, and potential for licensing agreements.
- Legal expertise is vital for navigating patent validity, infringement, and potential challenges.
FAQs
Q1. What is the typical scope of chemical structure claims in Japanese pharmaceutical patents?
A1. They generally cover the core chemical scaffold with specific substituents, stereochemistry, and formulations, aiming for broad protection within the defined structural boundaries.
Q2. How does the Japanese patent system handle overlapping claims with prior art?
A2. The Japan Patent Office assesses inventive step and novelty, potentially narrowing claims during prosecution or rejecting them if prior art renders them obvious or non-novel.
Q3. Can method claims extending coverage to treatment utilize the same compound patent?
A3. Yes, method of treatment claims can be distinct, providing complementary protection. Their validity depends on regional laws regarding second medical use patents.
Q4. What are current trends influencing patent strategies in Japanese pharma?
A4. Trends include emphasizing process patents, securing broad compound claims, and leveraging combination use patents to extend exclusivity.
Q5. When can generic manufacturers challenge the patent?
A5. Post-expiry or via invalidation procedures if they can demonstrate invalidity or lack of inventive step based on prior art.
References
[1] Japan Patent Office (JPO). Patent prosecution guidelines. 2022.
[2] Takeda, K. et al., “Legal elements of pharmaceutical patenting in Japan,” Journal of Pharmaceutical Law, 2021.
[3] World Intellectual Property Organization (WIPO). Patent Landscape Reports, 2020.
